Fundraising FoxLabyRx
1 known investors
Find your way into LabyRx
Sign up to see every warm intro you have to LabyRx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LabyRx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LabyRx develops therapeutic cancer vaccines based on Labyrinthin, a protein target found on adenocarcinoma cells, using synthetic peptide immunotherapy to train the immune system to attack tumors. The company, an immuno-oncology biotech, also pursues monoclonal antibody drug development and combination treatments for patients with adenocarcinomas.
Investors · 1
Frequently asked questions
- What does LabyRx do?
- LabyRx develops therapeutic cancer vaccines based on Labyrinthin, a protein target found on adenocarcinoma cells, using synthetic peptide immunotherapy to train the immune system to attack tumors. The company, an immuno-oncology biotech, also pursues monoclonal antibody drug development and combination treatments for patients with adenocarcinomas.
- Who are LabyRx's investors?
- LabyRx's investors include Red Sails Investment.